Huixia Lv
- Molecular Biology top 10%
- Biomaterials top 1%
- Pharmaceutical Science top 0.5%
- Biomedical Engineering top 10%
- Pharmacology top 1%
- Co-authors
- Zhenhai ZhangJianping ZhouWere L. L. MunyendoAyman Y. WaddadXin JinSarra AbbadYinlong ZhangZhen-Hai Zhang
- Topics
- Nanoparticle-Based Drug Delivery (17 papers)Advanced Drug Delivery Systems (15 papers)RNA Interference and Gene Delivery (13 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBiomaterials
- Partner nations
- ChinaPakistanUnited States
In The Last Decade
Huixia Lv
74 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 121
- Molecular Biology 1.1k
- Biomaterials 709
- Pharmaceutical Science 694
- Biomedical Engineering 405
- Pharmacology 297
Countries citing papers authored by Huixia Lv
This map shows the geographic impact of Huixia Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huixia Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huixia Lv more than expected).
Fields of papers citing papers by Huixia Lv
This network shows the impact of papers produced by Huixia Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huixia Lv. The network helps show where Huixia Lv may publish in the future.
Co-authorship network of co-authors of Huixia Lv
This figure shows the co-authorship network connecting the top 25 collaborators of Huixia Lv. A scholar is included among the top collaborators of Huixia Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huixia Lv. Huixia Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 63 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 23 | |
| 7 | 7 | |
| 8 | 12 | |
| 9 | 40 | |
| 10 | 9 | |
| 11 | 16 | |
| 12 | 13 | |
| 13 | 20 | |
| 14 | 21 | |
| 15 | 30 | |
| 16 | 60 | |
| 17 | 156 | |
| 18 | 26 | |
| 19 | 304 | |
| 20 | 22 |
About Huixia Lv
Huixia Lv is a scholar working on Pharmaceutical Science, Biomaterials and Pharmacology, having authored 77 papers that have together received 2.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (17 papers), Advanced Drug Delivery Systems (15 papers) and RNA Interference and Gene Delivery (13 papers). The work is most often cited by research in Pharmaceutical Science (694 citations), Biomaterials (709 citations) and Pharmacology (297 citations). Huixia Lv has collaborated with scholars based in China, Pakistan and United States. Frequent co-authors include Zhenhai Zhang, Jianping Zhou, Zhenhai Zhang, Were L. L. Munyendo, Ayman Y. Waddad, Xin Jin, Sarra Abbad, Yinlong Zhang, Jianping Zhou and Zhen-Hai Zhang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.